AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

(NASDAQ:ATON), New York, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (“AlphaTON Capital” or the “Company”) (Nasdaq: ATON), a specialized digital asset treasury company focused on the Telegram ecosystem, today announced a strategic joint venture with PagoPay to develop and launch a crypto-enabled Mastercard payment card program that enables cardholders to natively spend […]

Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025

(NASDAQ:MLYS), RADNOR, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the

Blaqclouds, Inc. Announces the November 6, 2025 Official Launch of ApolloID — The Web3 Identity Layer of the ZEUS Ecosystem

(PinkSheets:BCDS),(Pinksheets:BCDS), ROBESONIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — Blaqclouds, Inc. (OTC: BCDS), a leading innovator in decentralized Web3 infrastructure and blockchain technology, proudly announces that on November 6, 2025, at 5:00 PM EDT, Blaqclouds is official launching ApolloID, the next-generation Web3 identity and domain registry platform built exclusively for the Apollo Wallet. ApolloID introduces

Apollo Funds Complete Acquisition of Stream Data Centers

(NYSE:APO),(NASDAQ:PFG), NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds (the “Apollo Funds”) have completed the previously announced acquisition of a majority interest in Stream Data Centers (“SDC” or the “Company”), a leading developer and operator of hyperscale data center campuses across the United States. As part of

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

(NASDAQ:BLTE), SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, November 10, 2025, at 4:30 p.m. Eastern Time to discuss the

LM Funding America Announces $1.5 Million Share Repurchase Program

(NASDAQ:LMFA), TAMPA, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced that its Board of Directors has authorized a share repurchase program to buy up to $1.5 million of the Company's outstanding common stock. The authorization represents approximately

Board of Advisors, LLC (BA) Celebrates a Decade of Innovation with Q4 National Summit for High-Growth Entrepreneurs and Investors in Dallas, Nov.3-7

-2025 is BA's most significant year yet with new locations and an expanding set of programs to facilitate deal flow, high-power networking, and strategic support for company growth- DALLAS, Nov. 03, 2025 (GLOBE NEWSWIRE) — Board of Advisors (BA), the premier private network for high-growth entrepreneurs, investors, and visionaries, will enter its second decade of

Kyverna Therapeutics Secures up to $150 Million in Non-Dilutive Financing from Oxford Finance

(NASDAQ:KYTX), Initial funding of $25 million from the first of four tranches Facility strengthens Kyverna's financial flexibility, further supporting advancement of its late-stage indications in generalized myasthenia gravis (gMG) and stiff person syndrome (SPS), while also accelerating pre-launch activities Topline data readout of registrational Phase 2 SPS trial now expected in early 2026; narrowed from

Aardvark Therapeutics to Present at Upcoming Investor Conferences in November

(NASDAQ:AARD), SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present at the following conferences during November: Stifel 2025 Healthcare Conference in New YorkPresentation: Tuesday,

Inseego Strengthens Board of Directors with Experienced Operational Leaders in Carrier, AI, and SaaS

(NASDAQ:INSG),(NASDAQ:EXTR),(NASDAQ:ZD),(NASDAQ:SATS), SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Inseego Corp. (Nasdaq: INSG), a global leader in 5G mobile broadband and 5G fixed wireless access (FWA) solutions, announced today that Nabil Bukhari and Stephen Bye are joining its Board of Directors. Both operating executives bring extensive experience in wireless networking, SaaS, and AI, combined with

Scroll to Top